Published in Nanomedicine on January 29, 2014
Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases. Biogerontology (2014) 0.87
Pathophysiology Associated with Traumatic Brain Injury: Current Treatments and Potential Novel Therapeutics. Cell Mol Neurobiol (2016) 0.86
Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases. Nanomedicine (2015) 0.82
Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett (2006) 3.94
Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res (1997) 3.63
Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods (2004) 2.38
Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther (2006) 1.95
The magnetofection method: using magnetic force to enhance gene delivery. Biol Chem (2003) 1.66
New perspectives on central and peripheral immune responses to acute traumatic brain injury. J Neuroinflammation (2012) 1.34
Temporary focal ischemia in the mouse: technical aspects and patterns of Fluoro-Jade evident neurodegeneration. Brain Res (2005) 1.18
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. Biotechnol Adv (2011) 1.09
Lateral fluid percussion injury of the brain induces CCL20 inflammatory chemokine expression in rats. J Neuroinflammation (2011) 1.09
Magnetic nanoparticles as gene delivery agents: enhanced transfection in the presence of oscillating magnet arrays. Nanotechnology (2008) 1.07
Chitosan produces potent neuroprotection and physiological recovery following traumatic spinal cord injury. J Exp Biol (2010) 1.06
Gene delivery to respiratory epithelial cells by magnetofection. J Gene Med (2004) 1.06
Enhancing and targeting nucleic acid delivery by magnetic force. Expert Opin Biol Ther (2003) 1.03
Ex vivo magnetofection with magnetic nanoparticles: a novel platform for nonviral tissue engineering. Artif Organs (2008) 0.95
Dual-purpose magnetic micelles for MRI and gene delivery. J Control Release (2012) 0.93
Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier. Curr Cancer Drug Targets (2012) 0.91
The significance of mild traumatic brain injury to cognition and self-reported symptoms in long-term recovery from injury. J Clin Exp Neuropsychol (2008) 0.90
Slowing down after a mild traumatic brain injury: a strategy to improve cognitive task performance? Arch Clin Neuropsychol (2011) 0.90
Polyethylenimine improves the transfection efficiency of primary cultures of post-mitotic rat fetal hypothalamic neurons. J Neurosci Methods (2003) 0.88
Poly(ethylene imine)-g-chitosan using EX-810 as a spacer for nonviral gene delivery vectors. J Biomed Mater Res A (2009) 0.88
A novel adenoviral vector labeled with superparamagnetic iron oxide nanoparticles for real-time tracking of viral delivery. J Clin Neurosci (2012) 0.86
Static magnetic fields affect capillary flow of red blood cells in striated skin muscle. Microcirculation (2008) 0.86
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain. Mol Pharm (2013) 0.85
The scope of early traumatic brain injury as a long-term health concern in two nationwide samples: prevalence and prognostic factors. Brain Inj (2012) 0.84
Intracellular Delivery of siRNA by Polycationic Superparamagnetic Nanoparticles. J Drug Deliv (2012) 0.82
Magnetic field-assisted gene delivery: achievements and therapeutic potential. Curr Gene Ther (2012) 0.81
MagnetofectionTM platform: from magnetic nanoparticles to novel nucleic acid therapeutics. Ther Deliv (2011) 0.79
On designing stable magnetic vectors as carriers for malaria DNA vaccine. Colloids Surf B Biointerfaces (2012) 0.79
A novel approach for nucleic acid delivery into cancer cells. Medicina (Kaunas) (2012) 0.77